The novel findings of this study are: (1) improvements in CK, LDH, CRP, troponin-I, d-dimer, Creatinine, urea, K, Na, WBC, neutrophils, lymphocytes, RBC, platelets, hemoglobin, and hematocrit were seen with eight weeks of MICT alone and with RT alone in this cohort of patients surviving COVID-19, (2) the MICT acted synergistically with the RT to induce profound alleviations in the biochemical and hematological variables studied. Here, CRP is linked to COVID-19.